Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|11|2722-2729

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.11, 2015-11, pp. : 2722-2729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Air Ambulance Delivery and Administration of Four‐factor Prothrombin Complex Concentrate Is Feasible and Decreases Time to Anticoagulation Reversal

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 25, Iss. 1, 2018-01 ,pp. : 33-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 12, 2015-12 ,pp. : 2220-2226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of prothrombin complex concentrate administration and hematoma enlargement in non–vitamin K antagonist oral anticoagulant–related intracerebral hemorrhage

By  

ANNALS OF NEUROLOGY, Vol. 83, Iss. 1, 2018-01 ,pp. : 186-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prothrombin Complex Concentrates for Urgent Anticoagulation Reversal in Patients with Intracranial Haemorrhage

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 5, 2009-12 ,pp. : 259-265

Karger

Access to resources Recommend Favorite

Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 16, Iss. 1, 2018-01 ,pp. : 54-64

John Wiley & Sons Inc

Access to resources Recommend Favorite